FDA Panel Is First Key Test for Biden COVID-19 Booster Plan

NPR News Now
|

Automatic TRANSCRIPT

The food and drug administration is meeting today to review pfizer's request for third dose of its covert nineteen vaccine. Npr's windsor johnston reports some health. Experts have questioned whether a booster shot is necessary at this point a key. Fda advisory panel convenes today to discuss. Whether there's enough proof that a booster dose of the cova vaccine developed by pfizer is safe and effective citing data from recent studies. Pfizer argues that. Yo protection against severe disease is holding strong in the united states immunity against milder infection. Wayne somewhere around six to eight months after the second dose. The pharmaceutical company also says those. Antibodies appear strong enough to protect people against the highly contagious delta variant. If the fda decides to recommend the boosters the cdc will then have to decide who should get the additional doses windsor johnston

Coming up next